Lasa Supergenerics Ltd. Submits SDD Compliance Certificate for Q3 FY26
Lasa Supergenerics Limited submitted its SDD Compliance Certificate for the quarter ended December 31, 2025. The company confirmed adherence to SEBI (Prohibition of Insider Trading) Regulations, 2015, with a functional and secure Structured Digital Database. Two required events were captured during the quarter.
This is a routine compliance filing related to insider trading regulations and does not have a direct material impact on the company's operations or financial performance.
The announcement is a routine compliance filing and does not contain any positive or negative financial or business developments.
Lasa Supergenerics Limited has submitted its Compliance Certificate for the Structured Digital Database (SDD) for the quarter ended December 31, 2025. The certificate, issued as per the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, confirms the company's adherence to the regulations.
The Compliance Officer, Mitti Jain, certified that the company has a functional SDD in place, with controlled access and an audit trail. All Unpublished Price Sensitive Information (UPSI) disseminated in the previous quarter was captured, along with its nature, date, and time. The database is maintained internally, is non-tamperable, and capable of retaining records for eight years. The company was required to capture two events during the quarter and has successfully done so.
No non-compliance was observed in the previous quarter, and therefore, no remedial actions were required.
What to do with a filing like this
Lasa Supergenerics Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Lasa Supergenerics Limited. Read the original for the full detail.